Skip to main content
Clinical Trials/NCT03629353
NCT03629353CompletedNot Applicable

The Efficacy of Transnasal Humidified Rapid-insufflation Ventilatory Exchange in Patients Undergoing Laryngeal Microsurgery: a Randomized Controlled Trial

Seoul National University Hospital2 sites in 1 country126 target enrollmentStarted: August 17, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
126
Locations
2
Primary Endpoint
lowest oxygen saturation

Study Overview

Brief Summary

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) was revealed to prolong apneic time with a slow increase in carbon dioxide; thus, has been used for preoxygenation in patients with difficult airways or requiring rapid sequence induction in general anesthesia.

However, in patients undergoing hypopharyngeal and laryngo-tracheal surgery, THRIVE during operation can be advantageous by allowing tubeless surgical field with sufficient oxygenation.

Therefore, the investigators conducted this study to evaluate the efficacy of THRIVE on prolonged apneic time with enhanced surgical conditions in patients with laryngeal microsurgery.

Detailed Description

Patients undergoing laryngeal microsurgery will be randomized into either intubation group or THRIVE group.

On arriving operating room, the patients will be preoxygenated by facemask or high flow nasal cannula with 100% oxygen for 3 minutes according to the allocated group. After inducing general anesthesia, patients in intubation group will be oxygenated by endotracheal tube, while patients in THRIVE group will be oxygenated by high flow nasal cannula with flow rate of 70L/min. During the surgery, the endotracheal tube can be removed and reintubated in intubation group patients to provide surgical field by a surgeon, respectively.

The monitored pulse oximetry, oxygen reserve index, and transcutaneous partial pressure of carbon dioxide will be recorded during surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients undergoing laryngeal microsurgery
  • ASA class I-III

Exclusion Criteria

  • patients scheduled for laryngeal microsurgery using CO2 laser
  • patients with increased intracranial pressure
  • patients with skull base defect
  • patients with chronic obstructive pulmonary disease
  • patients with pulmonary hypertension
  • patients requiring rapid sequence induction

Outcomes

Primary Outcomes

lowest oxygen saturation

Time Frame: from the time of starting laryngeal microsurgery till the end of the surgery

lowest oxygen saturation monitored by pulse oximetry during laryngeal microsurgery

Secondary Outcomes

  • highest transcutaneous partial pressure of carbon dioxide(from the time of starting laryngeal microsurgery till the end of the surgery)
  • lowest oxygen reserve index(from the time of starting laryngeal microsurgery till the end of the surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Youn Joung Cho, MD

Clinical assistant professor

Seoul National University Hospital

Study Sites (2)

Loading locations...

Similar Trials